NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$18.48 USD
-0.64 (-3.32%)
Updated Jul 18, 2024 04:00 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO7/25/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 16.28% |
ABR | 2.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.59 |
Next Year | -1.69 |
EPS (TTM) | -1.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 136.46M | 139.57M | 556.35M | 597.27M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 139.60M | 143.20M | 567.00M | 616.50M |
Low Estimate | 135.10M | 135.20M | 546.10M | 581.40M |
Year ago Sales | 126.05M | 127.32M | 509.34M | 556.35M |
Year over Year Growth Est. | 8.26% | 9.62% | 9.23% | 7.36% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.41 | -1.59 | -1.69 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.41 | -0.39 | -1.52 | -1.42 |
High Estimate | -0.30 | -0.33 | -1.39 | -1.42 |
Low Estimate | -0.44 | -0.45 | -1.73 | -2.03 |
Year ago EPS | -0.54 | -0.46 | -1.95 | -1.59 |
Year over Year Growth Est. | 25.93% | 10.87% | 18.46% | -6.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.41 | -1.59 | -1.69 |
7 Days Ago | -0.40 | -0.41 | -1.59 | -1.69 |
30 Days Ago | -0.40 | -0.41 | -1.59 | -1.69 |
60 Days Ago | -0.41 | -0.42 | -1.64 | -1.76 |
90 Days Ago | -0.44 | -0.45 | -1.78 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.41 | -1.59 | -1.69 |
Zacks Consensus Estimate | -0.40 | -0.41 | -1.59 | -1.69 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.45 | -0.46 | -0.54 | NA |
Estimate | -0.43 | -0.53 | -0.52 | -0.50 | NA |
Difference | 0.07 | 0.08 | 0.06 | -0.04 | 0.04 |
Surprise | 16.28% | 15.09% | 11.54% | -8.00% | 8.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more